Recent successes in therapeutics for Ebola virus disease: no time for complacency

The PALM trial in the Democratic Republic of the Congo identified a statistically significant survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute Ebola virus disease; however, substantial gaps remain in improving the outcomes of acute Ebola virus disease and for...

Descripción completa

Detalles Bibliográficos
Autores principales: Iversen, Patrick L, Kane, Christopher D, Zeng, Xiankun, Panchal, Rekha G, Warren, Travis K, Radoshitzky, Sheli R, Kuhn, Jens H, Mudhasani, Rajini R, Cooper, Christopher L, Shurtleff, Amy C, Nasar, Farooq, Sunay, Melek ME, Duplantier, Allen J, Eaton, Brett P, Zumbrun, Elizabeth E, Bixler, Sandra L, Martin, Shannon, Meinig, J Matthew, Chiang, Chih-Yuan, Sanchez-Lockhart, Mariano, Palacios, Gustavo F, Kugelman, Jeffrey R, Martins, Karen A, Pitt, Margaret L, Crozier, Ian, Saunders, David L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302789/
https://www.ncbi.nlm.nih.gov/pubmed/32563280
http://dx.doi.org/10.1016/S1473-3099(20)30282-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302789/
https://www.ncbi.nlm.nih.gov/pubmed/32563280
http://dx.doi.org/10.1016/S1473-3099(20)30282-6

Ejemplares similares